Literature DB >> 12480261

Blood dendritic cells and DC-poietins in systemic lupus erythematosus.

Michelle A Gill1, Patrick Blanco, Edsel Arce, Virginia Pascual, Jacques Banchereau, A Karolina Palucka.   

Abstract

Dendritic cells (DCs) control immunity and tolerance. Hence, we surmised that systemic lupus erythematosus (SLE), a systemic autoimmune disease with autoreactive T and B cells, might be due to alterations in DC homeostasis. Taken together, our results demonstrate profound alterations of DCs and DC-poietins homeostasis in SLE. Elevated levels of interferon-alpha (IFN) in serum of SLE patients coexist with decreased numbers of cells producing IFN-alpha, i.e., plasmacytoid dendritic cells (PDCs). Decreased numbers of circulating DCs correlate with increased levels of soluble tumor necrosis factor (TNF) receptors, thus suggesting the potential role of TNF pathway in the observed DC alterations. Finally, increased FMS-like tyrosine kinase 3-ligand (FLT3-L) and its correlation with soluble TNF receptors suggest a physiologic response to compensate low DC numbers. Although IFN-alpha remains at the center of immunologic aberrations in SLE, it remains to be determined whether increased shedding of soluble TNF receptors could also be ascribed to IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12480261     DOI: 10.1016/s0198-8859(02)00756-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  35 in total

Review 1.  Dendritic cells: potential triggers of autoimmunity and targets for therapy.

Authors:  J A Hardin
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

Review 2.  Contribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosus.

Authors:  Juan P Mackern-Oberti; Carolina Llanos; Claudia A Riedel; Susan M Bueno; Alexis M Kalergis
Journal:  Immunology       Date:  2015-10-12       Impact factor: 7.397

Review 3.  Myeloid Populations in Systemic Autoimmune Diseases.

Authors:  María Morell; Nieves Varela; Concepción Marañón
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

4.  Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus.

Authors:  K Migita; T Miyashita; Y Maeda; H Kimura; M Nakamura; H Yatsuhashi; H Ishibashi; K Eguchi
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

5.  Murine germinal center B cells require functional Fms-like tyrosine kinase 3 signaling for IgG1 class-switch recombination.

Authors:  Mattias N D Svensson; Karin M E Andersson; Caroline Wasén; Malin C Erlandsson; Merja Nurkkala-Karlsson; Ing-Marie Jonsson; Mikael Brisslert; Mats Bemark; Maria I Bokarewa
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-16       Impact factor: 11.205

6.  Systemic dendritic cell mobilization associated with administration of FLT3 ligand to SIV- and SHIV-infected macaques.

Authors:  R Keith Reeves; Qing Wei; Jackie Stallworth; Patricia N Fultz
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

7.  Impairment of monocyte-derived dendritic cells in idiopathic pulmonary arterial hypertension.

Authors:  Weiyan Wang; Hui Yan; Weiguo Zhu; Yu Cui; Junzhu Chen; Xingxiang Wang; Shan Li; Jianhua Zhu
Journal:  J Clin Immunol       Date:  2009-08-20       Impact factor: 8.317

Review 8.  Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.

Authors:  Frédéric Coutant; Pierre Miossec
Journal:  Nat Rev Rheumatol       Date:  2016-09-22       Impact factor: 20.543

Review 9.  How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets.

Authors:  Virginia Pascual; Florence Allantaz; Pinakeen Patel; A Karolina Palucka; Damien Chaussabel; Jacques Banchereau
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

10.  The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus.

Authors:  Ilan Ben-Zvi; Cynthia Aranow; Meggan Mackay; Anfisa Stanevsky; Diane L Kamen; L Manuela Marinescu; Christopher E Collins; Gary S Gilkeson; Betty Diamond; John A Hardin
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.